Ryan S. Napierski
President and CEO at Nu Skin Enterprises Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Nu Skin Enterprises Inc., 3 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Nu Skin Enterprises Inc. May 28, 202699.2%
-
Nu Skin Enterprises Inc. May 29, 202596.4%
-
Nu Skin Enterprises Inc. June 5, 202497.1%
-
Nu Skin Enterprises Inc. June 7, 202397.9%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 6, 2026 | Nu Skin Enterprises Inc. | Grant or award | +282,353 | — | — |
| Feb 26, 2026 | Nu Skin Enterprises Inc. | Shares withheld for tax | −124,802 | $8.63 | $1,077,041 |
| Feb 15, 2026 | Nu Skin Enterprises Inc. | Shares withheld for tax | −49,037 | $8.36 | $409,949 |
| Feb 10, 2026 | Nu Skin Enterprises Inc. | Grant or award | +42,970 | — | — |
| Feb 10, 2026 | Nu Skin Enterprises Inc. | Grant or award | +206,988 | — | — |
| Feb 26, 2025 | Nu Skin Enterprises Inc. | Grant or award | +310,479 | — | — |
| Feb 15, 2025 | Nu Skin Enterprises Inc. | Shares withheld for tax | −40,857 | $7.56 | $308,879 |
| Feb 12, 2025 | Nu Skin Enterprises Inc. | Grant or award | +17,694 | — | — |
| Feb 27, 2024 | Nu Skin Enterprises Inc. | Grant or award | +189,574 | — | — |
| Feb 15, 2024 | Nu Skin Enterprises Inc. | Shares withheld for tax | −12,573 | $13.82 | $173,759 |
| Feb 13, 2024 | Nu Skin Enterprises Inc. | Grant or award | +10,332 | — | — |
| Feb 28, 2023 | Nu Skin Enterprises Inc. | Option exercise | +10,000 | $30.63 | $306,300 |
| Feb 28, 2023 | Nu Skin Enterprises Inc. | Open-market sale | −9,400 | $40.38 | $379,572 |
| Feb 28, 2023 | Nu Skin Enterprises Inc. | Open-market sale | −600 | $40.97 | $24,582 |
| Feb 27, 2023 | Nu Skin Enterprises Inc. | Option exercise | +21,513 | $30.63 | $658,943 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.